E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/16/2018 in the Prospect News Emerging Markets Daily.

India’s Piramal board approves placement of Rs. 5 billion debentures

By Sarah Lizee

Olympia, Wash., Nov. 16 – Piramal Enterprises Ltd.’s administrative committee of its board of directors approved a private placement of Rs. 5 billion of secured redeemable nonconvertible debentures, according to a notice filed with the Bombay Stock Exchange.

The committee approved the allotment of 5,000 debentures having a face value of Rs. 1 million each.

The debentures will be listed on the wholesale debt market segment of National Stock Exchange of India Ltd.

Piramal Enterprises, formerly Piramal Healthcare Ltd., is a Mumbai-based subsidiary of the Piramal Group.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.